

Check your study's UK Radiation Assurance requirements
Complete our short assessment to understand your study's likely Radiation Assurance route, specialist review requirements, required information and next steps.
Takes a few minutes. No cost, no obligation.
Your answers are used to provide your assessment and, where requested, help Nclusiv respond to your enquiry. Please do not enter patient-identifiable information.
What this assessment clarifies
- Your likely UK radiation assurance route
- Whether MPE and CRE reviews may be required
- Whether nuclear medicine, ARSAC or radiotherapy specialists may be needed
- Relevant documentation and next steps
Radiation assurance expertise trusted across pharma, CROs and the NHS
Expert-guided study planning in a few short steps
The assessment builds a clear picture of your study, then points you toward the right route and specialists.
- 1
Describe your study
Tell us your study reference, the imaging or procedures involved, and any planned amendments.
- 2
Flag radiation factors
We capture whether nuclear medicine, ARSAC, radiotherapy or diagnostic imaging may be in scope.
- 3
Identify your likely route
See your probable route and whether MPE and CRE reviews may apply.
- 4
See your next steps
Get clear pointers on relevant documentation and how to commission a specialist review.
Built for UK teams planning radiation studies
If your study may involve ionising radiation, this assessment helps you plan the review pathway before deadlines apply pressure.
Pharmaceutical companies
Sponsors planning trials with imaging or radiation components who need early clarity.
CROs
Contract research organisations coordinating radiation assurance across studies.
Clinical trial units
NHS and academic units confirming the right MPE and CRE pathway.
Research teams
Study teams scoping documentation and specialist needs before submission.
Clarity across every radiation review pathway
Standard diagnostic review
Where a standard diagnostic radiation review appears likely.
Nuclear medicine and ARSAC
Whether nuclear medicine and ARSAC considerations may need specialist input.
Radiotherapy review
Where specialist radiotherapy or therapeutic nuclear medicine review may be required.
Amendment review
Whether an amendment could change radiation exposure, dose or procedure.
Expert clarification
Where expert clarification is needed before a route can be confirmed.
Documentation and next steps
Which study documents are relevant and what to prepare next.
An important note on scope
This assessment supports study planning only. It is not a scored test, a regulatory decision, or a substitute for formal MPE and CRE review. Findings are indicative and should be confirmed with an appropriately HRA-registered reviewer.
Commissioned reviews: 5 working days standard / 2 working days expedited, subject to study scope and reviewer availability.
When a review is commissioned, our appropriately HRA-registered MPE and CRE reviewers work to keep your timelines intact. We support IRAS direct submission and HRA self-managed routes, and resolve queries promptly so your study can progress.
Check your study's UK Radiation Assurance requirements
Complete the short, expert-guided assessment for clear direction on your likely route, specialist needs and next steps.
For study planning only. Not a substitute for formal MPE and CRE review.